Terns Pharmaceuticals (TERN)
NASDAQ:TERN
Holding TERN?
Track your performance easily

Terns Pharmaceuticals (TERN) Income Statement

328 Followers

Terns Pharmaceuticals Income Statement

Last quarter (Q2 2024), Terns Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Terns Pharmaceuticals's net income was $-22.74M. See Terns Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 1.00M$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
---$ 1.00M--
Operating Expense
$ 105.33M$ 102.56M$ 62.03M$ 50.86M$ 37.02M$ 70.20M
Operating Income
$ -105.33M$ -102.56M$ -62.03M$ -49.86M$ -37.02M$ -70.20M
Net Non Operating Interest Income Expense
----$ 55.00K$ 1.20M
Other Income Expense
$ -12.84M$ -12.59M$ -2.04M$ -210.00K$ -2.79M$ 154.00K
Pretax Income
$ -92.48M$ -89.97M$ -59.99M$ -49.65M$ -39.76M$ -68.84M
Tax Provision
$ 288.00K$ 239.00K$ 358.00K$ 508.00K$ 813.00K$ -20.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -92.77M$ -90.21M$ -60.34M$ -50.16M$ -29.35M$ -68.61M
Basic EPS
$ -1.28$ -1.27$ -1.67$ -2.21$ -1.29$ -2.86
Diluted EPS
$ -1.28$ -1.27$ -1.67$ -2.21$ -1.29$ -2.86
Basic Average Shares
$ 291.75M$ 71.26M$ 36.03M$ 22.71M$ 22.72M$ 23.97M
Diluted Average Shares
$ 291.75M$ 71.26M$ 36.03M$ 22.71M$ 22.72M$ 23.97M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 105.33M$ 102.56M$ 62.03M$ 50.86M$ 37.02M$ 70.20M
Net Income From Continuing And Discontinued Operation
$ -92.77M$ -90.21M$ -60.34M$ -50.16M$ -40.05M$ -68.61M
Normalized Income
$ -45.92M-$ -47.39M$ -39.22M$ -40.05M$ -68.61M
Interest Expense
------
EBIT
$ -105.33M$ -102.56M$ -59.99M$ -49.65M$ -37.02M$ -70.20M
EBITDA
$ -104.41M$ -101.68M$ -58.87M$ -48.26M$ -36.63M$ -70.00M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis